10x Genomics
85 hedge funds and large institutions have $2.35B invested in 10x Genomics in 2019 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 26 increasing their positions, 19 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
85
Holders Change
-7
Holders Change %
-7.61%
% of All Funds
1.68%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.1%
New
26
Increased
26
Reduced
19
Closed
27
Calls
$5.9M
Puts
$2.68M
Net Calls
+$3.22M
Net Calls Change
+$3.22M
Top Buyers
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$51.8M |
| 2 |
Morgan Stanley
New York
|
+$48.3M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$29.4M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$24M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$15.3M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$37.9M |
| 2 |
BlackRock
New York
|
-$34.2M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$8.14M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$7.56M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$6.24M |
